Therefore, targeting components of the ISR pathway in combination with statin and dipyridamole treatment may be a novel therapeutic strategy for the treatment of gastric cancer patients with higher levels of HMGCS1 and these components in the future. The gene discussed is HMGCS1; the disease is gastric cancer.